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Abstract — Biosensors are self-contained analytical devices in which a bioreceptor is integrated with a 
transducer. The interaction between the bioreceptor and a target analyte generates a signal suitable for 
analytical purposes. In electrochemical biosensors, a change in the redox state of the biorecognition/analyte 
system generates a change in an electrochemical quantity which can be monitored by electroanalytical 
techniques. Electrochemical sensors can also be miniaturized using ultramicroelectrodes and nanoelectrodes 
and their arrays as transducers. These devices are characterized by high specificity and sensitivity and improved 
detection limits. Within the frame of the TRANS2CARE project, the Laboratory of Electrochemical Sensors 
(http://lsegroup.wix.com/website-lse-group) of the University Ca’ Foscari of Venice is collaborating with some 
of the project partners in order to develop bioelectrochemical sensors/nanosensors for clinical/molecular 
diagnostics.
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_____________________________________________________________________ 
1 BACKGROUND
An electrochemical biosensor is defined as an analytical device composed by two main elements, in 
close proximity or even integrated one on each other: a biological recognition element and a transducer 
(electrode) which converts the recognition event into a measurable signal. Affinity electrochemical 
biosensors exploit the interaction between the recognition molecule and its specific target, to produce 
a detectable signal. The recognition event is strongly influenced by the characteristics (e.g., shape and 
size) of the interacting biomolecules and high specificity and affinity are required to ensure a strong 
and stable interaction. Different kind of interactions can be exploited to this aim, such as antibody-
antigen complexes or the formation of the DNA double helix by hybridization between a probe and 
its complementary sequence. Electrochemical biosensors offer several advantages with respect to 
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other assays, because they are portable, cheap and the measurements are fast and easy to perform. 
Electrochemical sensors are furthermore provided with high sensitivity, high signal/noise ratios and 
can be miniaturized down to nm-size.
2 OBJECTIVES
Main objective of our research is the detection of DNA, proteins and other molecules of clinical interest 
by electrochemical detection strategies, employing nanostructured surfaces, nanoparticles, polymers 
with ionic properties, etc.
3 APPROACH & METHODS
1. Direct detection of molecules in biological samples (Fig. 1a) without functionalization of the 
electrode surface.
2. Modification of the electrode surface with a biological recognition layer (Fig. 1b), able to react 
specifically with a suitable target (= molecule of interest).
4 RESULTS
The main results concern the study and development of affinity biosensors suitable for the 
detection of DNA hybridization or antigen/antibody interactions. For the first case, ensembles of 
nanoelectrodes (NEEs) [1] are used as platforms where either, the template membrane that surrounds 
the nanoelectrodes [2, 3] or the electrodes themselves [4], are exploited for the immobilization of the 
biorecognition macromolecules. These two detection schemes are summarized in Fig. 2, where the 
detection is performed by cyclic voltammetry (CV).
Antigen/antibody immunoreactions are exploited to analyze the antibody tissue anti-transglutaminase 
(anti-tTG) involved in the coeliac disease, a widespread condition characterized by an inflammatory 
intestinal disease associated with malabsorption. The recognition and detection principles are 
summarized in Fig. 3, where the detection is performed by electrochemical impedance spectroscopy 
(EIS).
Moreover, the use of electrochemical sensors for the electroanalytical detection of the bile pigment 
bilirubin (BR) and its oxidation and reduction products has been studied. BR has been chosen as target 
molecule because of its clinical importance in several diseases [5]. Indeed, BR can be toxic under 
certain conditions, especially in neonates. However a mild hyperbilirubinaemia may have a protective 
Figure 1: Schematic representation of the approaches described above.
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Figure 3: a) Functionalization scheme of the gold electrode surface with the antigen/antibody complex; b) Faradaic 
impedance spectra recorded at a gold electrode after treatment with thiols (red curve), functionalization with tTG 
(blue curve), blocking (magenta curve) and incubation with anti-tTG (green curve). Measurements were performed 
in 1X PBS buffer in the presence of 25 mM [Fe(CN)6]
3-/4- at a potential of 0.22 V in a frequency range from 0.1 to 100 
kHz with an amplitude of 0.01 V.
Figure 2: Functionalization schemes of NEEs where either the polycarbonate membrane (a) or the gold electrode 
surface (b) are exploited for the immobilization of the oligonucleotides. Cyclic voltammograms reported on the 
right are recorded with functionalized NEEs in a 10 mM PBS solution (pH 7.4) containing FA+PF6
- as redox mediator, 
before (full black line) and after (full red line) the addition of 50 mM glucose. Dotted line CV shows the control signal 
in which an unmodified NEE is used. Scan rate 5 mV s-1.
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effect against ischemic cardiovascular diseases and tumour development [6]. For this purpose, a novel 
kind of carbon electrodes (namely, Pyrolized Photoresist Carbon Electrodes - PPCEs [7]) are applied to 
the electrochemical characterization of BR in aprotic solvent, namely dimethylsulfoxide (DMSO). PPCE 
presents good electrochemical performances comparable with those of a conventional glassy carbon 
electrode (GCE), allowing to detect multiple electro-oxidation and electro-reduction mechanisms 
of BR (Fig. 4), thanks to the wide potential window accessible in DMSO. Moreover, PPCEs can be 
photopatterned as miniaturized arrays.
Figure 4. Cyclic voltammogram of 1 mM BR recorded with PPCE in 0.1 M TBABF4, DMSO solution. Scan rate 10 mV s
-1.
Finally, the possibility to use PPCEs for the electrogeneration of the superoxide anion (O2-•) by simple 
electrochemical reduction of dissolved oxygen has been evaluated in detail. The additional study of 
the reactivity of O2-
• with BR allows us to evaluate and confirm the radical scavenging properties of BR.
5 POTENTIAL NEW PRODUCTS & SERVICES
Products: sensing devices for the detection of DNA sequences; novel biosensors with high sensitivity 
and specificity for both the label or label-free detection of anti-tissue transglutaminase (anti-tTG) for 
the diagnosis of the celiac disease ; electrochemical methods and devices for the fast analysis of total 
and conjugated bilirubin.
Service: development of rapid, sensitive, cost-effective and easy-to-use analytical devices suitable for 
point of care application. Such devices will allow to use simplified detection strategies, for analysis in 
small volume samples (few µL).
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6 CURRENT COLLABORATIONS
6.1   With other researchers:
•  Luigina De Leo (TRANS2CARE, PP9)*
• Mitja Martelanc (TRANS2CARE, PP3)
• Lovro Žiberna (TRANS2CARE, LP)
• Andrea Mardegan (Veneto Nanotech S.C.p.A., Marghera-Venice)
• Ljiljana Fruk (Karlsruhe Institute of Technology, Karlsruhe, Germany)
6.2   With companies:
• AB ANALITICA s.r.l. of Padova
6.3   With hospitals:
• Institute of Child Health IRCCS “Burlo Garofolo” of Trieste*
7 CONTACTS OR COLLABORATIONS NEEDED
For extending the fields of application we are looking for:
Antigen/antibody systems to be bound on the electrodes.
Redox enzymes for the development of electrocatalytic sensors.
Proposals for the application of electrochemical methods to the study of radicals and other species 
involved in oxidative stress and related processes.
For these reasons, collaborations with hospitals and companies are required. In addition, smart inputs 
from end-users can help in finding useful applications.
Target laboratories and companies:
1. Research and diagnostic laboratories
2. Companies specialized in the development and production of kits and diagnostic systems
3. Food companies
4. Companies working in the biomedical field
8 COMMUNICATION TOOLS
The high level of expertise in the field of electroanalytical chemistry as well as the high level of 
applicability, quality and performances of the presented methods is disseminated through the high 
quality scientific publications (see References 2-4, 7).
These topics have been presented at the following events:
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Oral presentations:
1. M. Silvestrini, P. Ugo, L. De Leo, T. Not, L. Žiberna, S. Passamonti, M. Martelanc, M. Franko, SENSITIVE 
MOLECULAR DIAGNOSTICS WITH ELECTROCHEMICAL BIOSENSORS AND ENSEMBLES OF 
NANOELECTRODES, workshop: Medicine for Nanotechnologies - Nanotechnologies for Medicine, 
NanotechItaly 2013, Venezia Mestre - Italy, November 29, 2013. Abstract in conference proceedings 
ISBN 978-88-6140-152-5.
2. M. Silvestrini, MEASURING BILIRUBIN IN SERUM USING ELECTROCHEMISTRY APPROACH, 
TRANS2CARE workshop - Bilirubin in Translational Medicine, Ferrara - Italy, June 6, 2013.
3. M. Silvestrini, MEASURING BILIRUBIN IN SERUM USING ELECTROCHEMISTRY APPROACH, Trans2Care 
workshop - Bilirubin in Translational Medicine, Izola - Slovenia, March 14 2013.
Posters:
1. M. Silvestrini, P. Ugo, ELECTROCHEMICAL BIOSENSORS FOR SENSITIVE MOLECULAR DIAGNOSTICS, 
Conference: Cross-Border Italy-Slovenia Biomedical Research: Are We Ready for Horizon 2020?, 
Trieste - Italy, February 27, 2014.
2. M. Silvestrini, A. Mardegan, M. Cettolin, L.M. Moretto, P. Scopece, P, Ugo, ELECTROANALYTICAL 
APPLICATIONS OF SENSORS BASED ON PYROLIZED PHOTORESIST CARBON ELECTRODES, 2nd 
National Conference of Sensors, Rome – Italy, February 19 – 21, 2014.
3. A. Petelin, Z. Jenko-Pražnikar, M. Jurdana, M. Čemažar, M. Martelanc, M. Franko, M. Silvestrini, P. Ugo, 
L. Žiberna, S. Passamonti, SERUM BILIRUBIN AS A BIOMARKER OF CARDIOVASCULAR PRE-DISEASE 
STATES: FROM ANALYTICAL APPROACHES TO CLINICAL VALUE, 6th Central European Conference 
“Chemistry towards Biology”, Trieste - Italy, September 10 - 13, 2013.
4. M. Silvestrini, P. Ugo, L. Žiberna, S. Passamonti, L. De Leo, T. Not, M. Martelanc, M. Franko, SENSITIVE 
MOLECULAR DIAGNOSTICS WITH ELECTROCHEMICAL BIOSENSORS AND ENSEMBLES OF 
NANOELECTRODES, 6th Central European Conference “Chemistry towards Biology”, Trieste - Italy, 
September 10 - 13, 2013.
5. M. Silvestrini, P. Ugo and Trans2Care network, NANOTECHNOLOGY IN HEALTH CONTROL: THE 
EXPERIENCE WITHIN THE TRANS2CARE NETWORK, NanotechItaly 2012, Venezia Mestre - Italy, 
November 1, 2012. Abstract in conference proceedings ISBN 978-886140-130-3.
These topics have been the subject of two projects written for the event Trieste Next:
1. Project for the event Nordest Technology Transfer - Trieste Next 2012. Title: Electroanalytic platform 
for the detection of molecules of environmental/biological interest. This project received the 
ENTERPRISE CITY PRIZE 2013 at the event that opened the sixth edition of the Festival Enterprise 
City at the Municipal Theatre of Vicenza on May 8, 2013.
2. Project for the event Nordest Technology Transfer - Trieste Next 2013. Title: Electrochemical 
biosensors and ensembles of nanoelectrodes for molecular diagnostics.
9 FUNDS NEEDED
9.1  For basic research (investigation of biological mechanisms): 50.000 €
9.2   For applied research (solutions for real-world problems): 20.000 €
9.3   For pilot & demonstrator activities (to develop a prototype): 50.000 €
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10 CONCLUSIONS
The know-how in the field of analytical application of electrochemical nano-biosensors acquired 
by the group at the University Ca’ Foscari thanks to the present project can be extended and find 
practical application to the determination of clinically relevant molecules. Our participation in the 
TRANS2CARE project together with the other specialized partners, each bringing different know-how 
ranging from biochemistry to clinical practice, constitutes an important occasion and a challenge for 
new developments in the field of molecular diagnostics. Electrochemical biosensors can indeed be 
very helpful for obtaining quick and reliable analytical information thanks to their sensitivity, relative 
low cost, possibility of decentralized use and simple applicability.
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